多囊卵巢综合征患者助孕方式的研究新进展
Research Progress of Assisted Pregnancy in Patients with Polycystic Ovary Syndrome
DOI: 10.12677/ACM.2023.133661, PDF,   
作者: 厉彦平, 腊晓琳*：新疆医科大学第一附属医院生殖中心，新疆 乌鲁木齐
关键词: 多囊卵巢综合征；助孕方式；卵巢过度刺激综合征；Polycystic Ovary Syndrome； Assisted Pregnancy； Ovarian Hyperstimulation Syndrome
摘要: 多囊卵巢综合征(Polycystic Ovary Syndrome, PCOS)是常见的女性内分泌疾病，也是引起女性无排卵不孕的主要原因。近年来对于PCOS患者的诊断及治疗等取得了显著进展，但全球范围内暂未明确PCOS不孕患者最优选的治疗方案。本文综述近年来PCOS患者的研究新进展，以期为临床诊疗提供有意义的参考。
Abstract: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women, which is also the main cause of infertility in women without ovulation. In recent years, remarkable progress has been made in the diagnosis and treatment of PCOS patients, but the optimal treatment plan of the world for infertility patients with PCOS has not been determined. This article reviews the research pro-gress of PCOS patients in recent years, in order to provide a meaningful reference for clinical diag-nosis and treatment.
文章引用：厉彦平, 腊晓琳. 多囊卵巢综合征患者助孕方式的研究新进展[J]. 临床医学进展, 2023, 13(3): 4603-4609. https://doi.org/10.12677/ACM.2023.133661

参考文献

[1] 中华医学会妇产科学分会内分泌学组及指南专家组. 多囊卵巢综合征中国诊疗指南[J]. 中华妇产科杂志, 2018, 53(1): 2-6.
[2] Joham, A.E., Norman, R.J., Stener-Victorin, E., et al. (2022) Polycystic Ovary Syndrome. The Lancet Diabetes & Endocrinology, 10, 668-680. [Google Scholar] [CrossRef] 
[3] (2004) Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS). Human Reproduction (Oxford, England), 19, 41-47. [Google Scholar] [CrossRef] [PubMed]
[4] Teede, H.J., Misso, M.L., Costello, M.F., et al. (2018) Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Human Reproduction (Oxford, England), 33, 1602-1618. [Google Scholar] [CrossRef] [PubMed]
[5] Cowan, S., Grassi, A., Monahan Couch, L., et al. (2023) Evi-dence-Based Lifestyle Guidelines and Self-Management Strategies Utilized by Women with Polycystic Ovary Syndrome. Nutrients, 15, 589. [Google Scholar] [CrossRef] [PubMed]
[6] Lim, S.S., Hutchison, S.K., Van Ryswyk, E., et al. (2019) Lifestyle Changes in Women with Polycystic Ovary Syndrome. The Cochrane Database of Systematic Reviews, 3, CD007506. [Google Scholar] [CrossRef] 
[7] Vyrides, A.A., El Mahdi, E. and Giannakou, K. (2022) Ovulation Induction Techniques in Women with Polycystic Ovary Syndrome. Frontiers in Medicine, 9, Article ID: 982230. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, R., Li, W., Bordewijk, E., et al. (2019) First-Line Ovulation Induction for Polycystic Ovary Syndrome: An Individual Participant Data Meta-Analysis. Human Reproduc-tion Update, 25, 717-732. [Google Scholar] [CrossRef] [PubMed]
[9] Tanbo, T., Mellembakken, J., Bjercke, S., et al. (2018) Ovulation In-duction in Polycystic Ovary Syndrome. Acta Obstetricia et Gynecologica Scandinavica, 97, 1162-1167. [Google Scholar] [CrossRef] [PubMed]
[10] 江波, 白文佩, 郁琦, 等. 生酮饮食干预多囊卵巢综合征中国专家共识(2018年版) [J]. 实用临床医药杂志, 2019, 23(1): 1-4.
[11] Barrea, L., Verde, L., Camajani, E., et al. (2023) Keto-genic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS). Current Nutrition Reports, 12, 56-64. [Google Scholar] [CrossRef] [PubMed]
[12] Huirne, J.A., Lambalk, C.B., Van Loenen, A.C., et al. (2004) Contemporary Pharmacological Manipulation in Assisted Reproduction. Drugs, 64, 297-322. [Google Scholar] [CrossRef] [PubMed]
[13] Tsiami, A., Goulis, D., Sotiriadis, A., et al. (2021) Higher Ovulation Rate with Letrozole as Compared with Clomiphene Citrate in Infertile Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Hormones (Athens), 20, 449-461. [Google Scholar] [CrossRef] [PubMed]
[14] Mitwally, M.F. and Casper, R.F. (2001) Use of an Aromatase Inhibitor for Induction of Ovulation in Patients with an Inadequate Response to Clomiphene Citrate. Fertility and Sterility, 75, 305-309. [Google Scholar] [CrossRef] 
[15] Franik, S., Le, Q., Kremer, J., et al. (2022) Aromatase Inhib-itors (Letrozole) for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome. Cochrane Database of Systematic Reviews, 9, CD010287. [Google Scholar] [CrossRef] 
[16] Shi, L., Ye, S., Gao, M., et al. (2022) Effect of Different Timing of Letrozole Initiation on Pregnancy Outcome in Polycystic Ovary Syndrome. Frontiers in Endocrinology, 13, Article ID: 1059609. [Google Scholar] [CrossRef] [PubMed]
[17] 华彩红, 尹山兰, 郝尚辉, 等. 来曲唑联合二甲双胍治疗耐克罗米芬多囊卵巢综合征不孕患者的临床疗效及胰岛素抵抗、性激素水平的影响[J]. 中国医院药学杂志, 2018, 38(22): 2343-2347.
[18] Facchinetti, F., Bizzarri, M., Benvenga, S., et al. (2015) Results from the International Con-sensus Conference on Myo-inositol and D-chiro-inositol in Obstetrics and Gynecology: the link between Metabolic Syn-drome and PCOS. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 195, 72-76. [Google Scholar] [CrossRef] [PubMed]
[19] (2017) Role of Metformin for Ovulation Induction in Infertile Pa-tients with Polycystic Ovary Syndrome (PCOS): A Guideline. Fertility and Sterility, 108, 426-441. [Google Scholar] [CrossRef] [PubMed]
[20] (2018) ACOG Practice Bulletin No. 194 Summary: Polycystic Ovary Syndrome. Obstetrics and Gynecology, 131, 1174-1176. [Google Scholar] [CrossRef] 
[21] Christin-Maitre, S. and Hugues, J.N. (2003) A Compara-tive Randomized Multicentric Study Comparing the Step-Up versus Step-Down Protocol in Polycystic Ovary Syndrome. Human Reproduction (Oxford, England), 18, 1626-1631. [Google Scholar] [CrossRef] [PubMed]
[22] Weiss, N.S., Kostova, E., Nahuis, M., et al. (2019) Gonadotrophins for Ovulation Induction in Women with Polycystic Ovary Syndrome. The Cochrane Database of Systematic Reviews, 1, CD010290. [Google Scholar] [CrossRef] 
[23] Farquhar, C., Brown, J. and Marjoribanks, J. (2012) Lap-aroscopic Drilling by Diathermy or Laser for Ovulation Induction in Anovulatory Polycystic Ovary Syndrome. The Cochrane Database of Systematic Reviews, No. 6, CD001122. [Google Scholar] [CrossRef] 
[24] Gao, Y., Jiang, S., Chen, L., et al. (2022) The Pregnancy Outcomes of Infertile Women with Polycystic Ovary Syndrome Undergoing Intrauterine Insemination with Different At-tempts of Previous Ovulation Induction. Frontiers in Endocrinology, 13, Article ID: 922605. [Google Scholar] [CrossRef] [PubMed]
[25] Wei, D., Liu, J.Y., Sun, Y., et al. (2019) Frozen versus Fresh Sin-gle Blastocyst Transfer in Ovulatory Women: A Multicentre, Randomised Controlled Trial. The Lancet (London, Eng-land), 393, 1310-1318. [Google Scholar] [CrossRef] 
[26] Atkinson, P., Koch, J. and Ledger, W.L. (2014) GnRH Ago-nist Trigger and a Freeze-All Strategy to Prevent Ovarian Hyperstimulation Syndrome: A Retrospective Study of OHSS Risk and Pregnancy Rates. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 54, 581-585. [Google Scholar] [CrossRef] [PubMed]
[27] Kuang, Y., Chen, Q., Fu, Y., et al. (2015) Medroxyprogesterone Acetate Is an Effective Oral Alternative for Preventing Premature Luteinizing Hormone Surges in Women Undergoing Controlled Ovarian Hyperstimulation for in Vitro Fertilization. Fertility and Sterility, 104, 62-70.e3. [Google Scholar] [CrossRef] [PubMed]
[28] 肖卓妮, 杨菁, 徐望明, 等. 拮抗剂与高孕激素下促排卵方案用于多囊卵巢综合征患者IVF治疗效果比较[J]. 生殖医学杂志, 2018, 27(12): 1170-1174.
[29] 王雪, 李东晗, 张瑞晓, 等. 多囊卵巢综合征患者应用高孕激素状态下促排卵方案的体外受精结局[J]. 中华生殖与避孕杂志, 2019, 39(4): 310-313.
[30] Zhang, W., Liang, T., Han, B., et al. (2022) Clinical Outcomes of in Vitro Maturation after Oocyte Retrieval with Gynecological Surgery for Refractory Polycystic Ovary Syndrome: A Retrospective Cohort Study. Frontiers in Endocrinology, 13, Article ID: 842037. [Google Scholar] [CrossRef] [PubMed]
[31] Yu, E.J., Yoon, T.K., Lee, W.S., et al. (2019) Obstetrical, Neonatal, and Long-Term Outcomes of Children Conceived from in Vitro Matured Oocytes. Fertility and Sterility, 112, 691-699. [Google Scholar] [CrossRef] [PubMed]
[32] Mostinckx, L., Segers, I., Belva, F., et al. (2019) Obstetric and Neonatal Outcome of ART in Patients with Polycystic Ovary Syndrome: IVM of Oocytes versus Controlled Ovarian Stimulation. Human Reproduction (Oxford, England), 34, 1595-1607. [Google Scholar] [CrossRef] [PubMed]

为你推荐